Correlation Between Allovir and APPTECH CORP

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Allovir and APPTECH CORP at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allovir and APPTECH CORP into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allovir and APPTECH CORP, you can compare the effects of market volatilities on Allovir and APPTECH CORP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allovir with a short position of APPTECH CORP. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allovir and APPTECH CORP.

Diversification Opportunities for Allovir and APPTECH CORP

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Allovir and APPTECH is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Allovir and APPTECH CORP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on APPTECH CORP and Allovir is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allovir are associated (or correlated) with APPTECH CORP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of APPTECH CORP has no effect on the direction of Allovir i.e., Allovir and APPTECH CORP go up and down completely randomly.

Pair Corralation between Allovir and APPTECH CORP

Given the investment horizon of 90 days Allovir is expected to generate 0.78 times more return on investment than APPTECH CORP. However, Allovir is 1.28 times less risky than APPTECH CORP. It trades about 0.05 of its potential returns per unit of risk. APPTECH CORP is currently generating about -0.01 per unit of risk. If you would invest  706.00  in Allovir on July 2, 2022 and sell it today you would earn a total of  79.00  from holding Allovir or generate 11.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Allovir  vs.  APPTECH CORP

 Performance (%) 
       Timeline  
Allovir 
Allovir Performance
11 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Allovir are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Allovir reported solid returns over the last few months and may actually be approaching a breakup point.

Allovir Price Channel

APPTECH CORP 
APPTECH Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in APPTECH CORP are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, APPTECH CORP showed solid returns over the last few months and may actually be approaching a breakup point.

APPTECH Price Channel

Allovir and APPTECH CORP Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Allovir and APPTECH CORP

The main advantage of trading using opposite Allovir and APPTECH CORP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allovir position performs unexpectedly, APPTECH CORP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in APPTECH CORP will offset losses from the drop in APPTECH CORP's long position.
Allovir vs. Dentsu Inc
Allovir vs. PUBLICIS GROUPE SA
Allovir vs. Insignia Systems
Allovir vs. Wpp Plc Ord
The idea behind Allovir and APPTECH CORP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
APPTECH CORP vs. Glencore International Plc
APPTECH CORP vs. Compania Mina Buenaventura
APPTECH CORP vs. Rio Tinto Plc
APPTECH CORP vs. MAG Silver Corp
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
CEO Directory
Screen CEOs from public companies around the world
Go